1. Tetramethylpyrazine inhibits the proliferation, invasiveness and migration of cervical cancer C33A cells by retarding the Hedgehog signaling pathway
   Jing Ren et al, 2022, Oncology Letters CrossRef
2. Tetramethylpyrazine: A review of the most recent research
   Tong Xu et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
3. Tetramethylpyrazine: A Review of Its Antitumor Potential and Mechanisms
   Shaojie Yang et al, 2021, Frontiers in Pharmacology CrossRef
4. 2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells
   Young Yun Jung et al, 2022, Biomolecules CrossRef
5. Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway
   Yi Zhou et al, 2020, International Journal of Oncology CrossRef
6. Tetramethylpyrazine: A review on its mechanisms and functions
   Jianguo Lin et al, 2022, Biomedicine & Pharmacotherapy CrossRef
7. Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways
   Haidy E. Michel et al, 2019, European Journal of Pharmacology CrossRef
8. Oncogenic role of FOXM1 in human prostate cancer (Review)
   Da Lee et al, 2023, Oncology Reports CrossRef
9. Tetramethylpyrazine inhibits proliferation of colon cancer cells in vitro
   Hua Li et al, 2021, World Journal of Clinical Cases CrossRef
10. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer
    Qi-Wei Li et al, 2021, Journal of Ethnopharmacology CrossRef